Veru Inc (NASDAQ: VERU)’s stock price has decreased by -8.78 compared to its previous closing price of 0.72. However, the company has seen a -11.09% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-05 that MIAMI, FL, Nov. 05, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced data from a meta-analysis presentation at ObesityWeek, which took place November 5, 2024, in San Antonio, Texas.
Is It Worth Investing in Veru Inc (NASDAQ: VERU) Right Now?
The 36-month beta value for VERU is at -0.49. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for VERU is 125.73M, and currently, shorts hold a 9.85% of that float. The average trading volume for VERU on November 13, 2024 was 624.60K shares.
VERU’s Market Performance
The stock of Veru Inc (VERU) has seen a -11.09% decrease in the past week, with a -29.31% drop in the past month, and a -17.64% fall in the past quarter. The volatility ratio for the week is 6.68%, and the volatility levels for the past 30 days are at 6.67% for VERU. The simple moving average for the past 20 days is -17.38% for VERU’s stock, with a -25.22% simple moving average for the past 200 days.
Analysts’ Opinion of VERU
Many brokerage firms have already submitted their reports for VERU stocks, with B. Riley Securities repeating the rating for VERU by listing it as a “Buy.” The predicted price for VERU in the upcoming period, according to B. Riley Securities is $5 based on the research report published on May 14, 2024 of the current year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see VERU reach a price target of $3. The rating they have provided for VERU stocks is “Outperform” according to the report published on March 28th, 2024.
Jefferies gave a rating of “Hold” to VERU, setting the target price at $1 in the report published on June 07th of the previous year.
VERU Trading at -18.81% from the 50-Day Moving Average
After a stumble in the market that brought VERU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.68% of loss for the given period.
Volatility was left at 6.67%, however, over the last 30 days, the volatility rate increased by 6.68%, as shares sank -27.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.58% lower at present.
During the last 5 trading sessions, VERU fell by -11.09%, which changed the moving average for the period of 200-days by +34.76% in comparison to the 20-day moving average, which settled at $0.7976. In addition, Veru Inc saw -8.47% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VERU starting from FISCH HARRY, who purchase 4,000 shares at the price of $1.25 back on May 24 ’24. After this action, FISCH HARRY now owns 774,736 shares of Veru Inc, valued at $5,000 using the latest closing price.
BARNETTE K GARY, the Chief Scientific Officer of Veru Inc, purchase 5,000 shares at $1.34 during a trade that took place back on May 24 ’24, which means that BARNETTE K GARY is holding 5,000 shares at $6,696 based on the most recent closing price.
Stock Fundamentals for VERU
Current profitability levels for the company are sitting at:
- -3.78 for the present operating margin
- 0.33 for the gross margin
The net margin for Veru Inc stands at -3.76. The total capital return value is set at -0.99. Equity return is now at value -135.95, with -63.11 for asset returns.
Based on Veru Inc (VERU), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at -2.53. The debt to equity ratio resting at 0.28. The interest coverage ratio of the stock is -82.68.
Currently, EBITDA for the company is -94.7 million with net debt to EBITDA at 0.37. When we switch over and look at the enterprise to sales, we see a ratio of 5.75. The receivables turnover for the company is 8.58for trailing twelve months and the total asset turnover is 0.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.62.
Conclusion
In conclusion, Veru Inc (VERU) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
